Shanghai Industrial Investment Co., a Chinese state-owned conglomerate, plans to launch an RMB50 billion (US$7.28 billion) fund for equity investments in China’s biopharmaceutical sector, said Zhou Jun, CEO and chairman of the company at the ninth State-Owned Assets Summit in Shanghai yesterday.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Read 2 Articles for Free with a Basic Account
Gain limited and restricted access to China Money Network.Register Basic Account
Subscribe for an annual subscription!
Enjoy comprehensive and exclusive data you can't find elsewhere!More Info
Already have an account or paid subscription?